![Ben Taylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben Taylor
Directeur Financier/CFO chez
RECURSION PHARMACEUTICALS, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Ben R.
Taylor is Chief Financial Officer & President-UK Region at Recursion Pharmaceuticals, Inc. since 2024.
Formerly, Chief Financial Officer & Executive Director at Exscientia AI Ltd. from 2020 to 2024.
Chief Financial & Strategy Officer, Director at Exscientia Ltd. Head-Emerging Pharm at Goldman Sachs & Co. LLC from 2012 to 2016.
Head-Commercial Pharm at Barclays Capital, Inc. from 2016 to 2017.
President & Chief Financial Officer at Tyme Technologies, Inc. from 2017 to 2020.
Chief Financial Officer at Aetion, Inc. in 2020.
Education includes undergraduate degree from Brown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 1 101 876 ( 0,21 % ) | 4 M $ | 31/05/2026 |
Postes actifs de Ben Taylor
| Sociétés | Poste | Début |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Directeur Financier/CFO | 20/11/2024 |
Anciens postes connus de Ben Taylor
| Sociétés | Poste | Fin |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Directeur Financier/CFO | 01/11/2024 |
Aetion, Inc.
 Aetion, Inc. Packaged SoftwareTechnology Services Develops real-world evidence platform that helps in decision-making activities related to healthcare sector | Directeur Financier/CFO | 01/11/2020 |
| TYME TECHNOLOGIES, INC. | Directeur Financier/CFO | 01/08/2020 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2017 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/02/2016 |
Formation de Ben Taylor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aetion, Inc.
Aetion, Inc. Packaged SoftwareTechnology Services Develops real-world evidence platform that helps in decision-making activities related to healthcare sector | Technology Services |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
